Skip to main content
Log in

Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Opioid use results in thousands of overdose deaths each year. To address this crisis, we need a better understanding of the neurobiological mechanisms that drive opioid abuse. The noninvasive imaging tools positron emission tomography (PET), functional magnetic resonance imaging (fMRI), and manganese-enhanced magnetic resonance imaging (MEMRI) can be used to identify how brain activity responds to acute opioid exposure and adapts to chronic drug treatment. These techniques can be performed in humans and animal models, and brain networks identified in animals closely map to the human brain. Animal models have the advantage of being able to systematically examine the independent effects of opioid exposure in a controlled environment accounting for the complex factors that drive opioid misuse in humans. This review synthesizes literature that utilized noninvasive neuroimaging tools (PET, fMRI, and MEMRI) measuring brain activity correlates in animals to understand the neurobiological consequences of exposure to abused opioids. A PubMed search in September 2023 identified 25 publications. These manuscripts were divided into 4 categories based on the route and duration of drug exposure (acute/chronic, active/passive administration). Within each category, the results were generally consistent across drug and imaging protocols. These papers cover a 20-year range and highlight the advancements in neuroimaging methodology during that time. These advances have enabled researchers to achieve greater resolution of brain regions altered by opioid exposure and to identify patterns of brain activation across regions (i.e., functional connectivity) and within subregions of structures. After describing the existing literature, we suggest areas where additional research is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

No data was used for the research described in the article.

Abbreviations

BOLD:

Blood oxygenation level-dependent

CPP:

Conditioned place preference

FDG:

2-Deoxy-2-[18F]fluoro-D-glucose

fMRI:

Functional magnetic resonance imaging

MEMRI:

Manganese-enhanced magnetic resonance imaging

PET:

Positron emission tomography

SPECT:

Single-photo emission computerized tomography

References

Download references

Funding

This research was funded by internal support from Penn State University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helen M. Kamens.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamens, H.M., Cramer, S., Hanley, R.N. et al. Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research. Psychopharmacology 240, 2459–2482 (2023). https://doi.org/10.1007/s00213-023-06477-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-023-06477-6

Keywords

Navigation